The Right Treatment Is
a Cell Cycle Away

4D Path has created the groundbreaking QPOR™ Platform designed to directly measure and quantify cell cycle deregulations and tumor microenvironment dynamics to predict a patient’s response to therapy in a way never before possible

Contact Us

Most cancer treatments target different phases of the cell cycle.

However, without the tools to characterize cell cycle dysfunction at the individual patient level, many cancer treatments fall short in providing truly personalized care.

The QPOR™ Platform was created to directly measure and quantify cell cycle deregulations and tumor microenvironment dynamics to precisely predict a patient’s response to therapy.


Unprecedented understanding of the tumor state

Devised to measure and quantify cell cycle deregulations and tumor microenvironment dynamics, unlocking valuable insights into the collective tumor state.

Precise prediction of tumor response to therapy

The QPOR™ Platform aims to deliver insights that may help researchers and clinicians understand which treatment most effectively targets the cell cycle deregulations found in a patient’s tumor.

Validated in clinical studies

The QPOR™ Platform demonstrated improved therapeutic response prediction in multiple tumor types, across different therapeutic classes, and in both clinical trial and real-world settings.


Partner with us

4D Path can partner with you and deliver customized treatment prediction signatures for your therapies of interest.

Together, we can unite in our purpose to deliver a true treatment match for patients with cancer, without delay or failure.

Contact Us About a Partnership Today